SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: betty moyers who wrote (16906)12/13/1998 11:11:00 PM
From: Mkilloran  Read Replies (1) | Respond to of 23519
 
betty...the EU approval board has approved Muse ..now each country in Europe makes the decision to alow for the sale of Muse in it's country.

This process takes about 30 days.

The agreement with Vivus and Astra is that after the 4 major countries in Europe grant permission for the sale of Muse then Astra pays the milestone fee of $8 million.

This all can happen by the last week in Dec of 98 or into the first week or so of Jan 99.